Hans Arwidsson

Dr. Hans Arwidsson is a Deputy Director at Ingrid Gjellan Fastighetsförmedling AB. He is on the Board of Directors at Eurocince Securities AB. Dr. Arwidsson was previously employed as a Chairman by Spago Nanomedical AB, a Chairman by Nanexa AB, a Chief Executive Officer by Biosergen AS, a President, Chief Executive Officer & Director by Eurocine Vaccines AB, a Chief Executive Officer by Lipocore Holding AB, a New Product Manager-Operations by AstraZeneca AB, a Vice President-Business Development by Astra Pharmaceuticals AB, and a Chief Executive Officer by LipoCore AB. He also served on the board at Xspray Pharma AB and Healthy Bizniz Europe AB. He received his graduate degree from the University of Uppsala, an MBA from Stockholm School of Economics and a doctorate degree from the University of Uppsala.